The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY is a premier academic journal dedicated to the vital intersections of clinical psychology, neuropsychology, and psychiatry, offering researchers and clinicians a platform to publish cutting-edge findings and comprehensive reviews. Published by Oxford University Press, the journal aims to advance the understanding of the cognitive and psychological aspects of neurological conditions through rigorous empirical research and innovative methodologies. With an impressive range of quartile rankings, including Q2 in Clinical Psychology and Neuropsychology, the journal stands out for its commitment to enhancing clinical practices and improving patient outcomes. Although it does not offer open access, its reputation is underscored by a competitive impact factor, making it a critical resource for professionals in the field looking to stay informed on the latest developments. The journal has been a respected outlet since 1986, and as it continues into 2024, it remains a beacon for scholarly discourse in neuropsychology and mental health.

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

The Journal of Clinical and Experimental Neuropsychology, published by Taylor & Francis Inc, stands as a pivotal resource in the realms of clinical psychology and neuropsychology. With an ISSN of 1380-3395 and an E-ISSN of 1744-411X, this journal has been a hallmark of scholarly excellence since its inception in 1985, continuing to shape the fields until 2024. It is renowned for its rigorous peer-reviewed articles and has garnered significant recognition, achieving a Q2 ranking in Clinical Psychology and Q3 rankings in various other relevant categories as of 2023. Serving as a bridge between clinical practice and experimental research, the journal underscores the critical role of neuropsychological assessment and intervention in enhancing mental health outcomes. Although not an open-access journal, it provides significant insights and empirical data that are crucial for researchers, clinicians, and students dedicated to advancing the understanding of cognitive functioning and psychological health. The journal's commitment to disseminating high-quality research contributes to its reputation and impact, making it a vital resource for those engaged in the study of neuropsychology and its clinical applications.

NEUROPSYCHOLOGY, published by the American Psychological Association, is a leading journal dedicated to advancing the field of neuropsychology and physiological psychology. With an ISSN of 0894-4105 and an E-ISSN of 1931-1559, the journal has established itself as a critical resource for researchers, clinicians, and students interested in the intersection of neuroscience and psychological practice. Recognized as a Q1 journal in its category for 2023, it holds a prominent position within the top quartile of neuropsychology journals, reflecting its rigorous peer-review process and high-quality publications. Covering a wide spectrum of topics from cognitive functions and brain-behavior relationships to clinical assessments and interventions, NEUROPSYCHOLOGY plays a pivotal role in disseminating significant research findings that enhance our understanding of the brain's complexities. Although this journal does not currently offer Open Access, it remains highly regarded for its contribution to the scientific community, as evidenced by its strong Scopus ranking of #34/76 in neuropsychology. As it marks over three decades of publication from 1990 to 2024, NEUROPSYCHOLOGY continues to be an essential publication for those committed to exploring and improving the field.

BEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.